Literature DB >> 22862843

Detection of haemagglutinin D222 polymorphisms in influenza A(H1N1)pdm09-infected patients by ultra-deep pyrosequencing.

M Selleri1, A Piralla, G Rozera, E Giombini, B Bartolini, I Abbate, G Campanini, F Rovida, L Dossena, M R Capobianchi, F Baldanti.   

Abstract

This study was aimed at establishing the genetic heterogeneity of influenza virus haemagglutinin (HA) gene quasi-species and the polymorphisms at codon 222, by application of ultra-deep pyrosequencing (UDPS) to respiratory samples from patients hospitalized for influenza A(H1N1)pdm09 infection, presenting with severe or moderate-mild disease. HA diversity was significantly higher in samples collected from patients with severe manifestations than in those from patients with moderate-mild manifestations (p 0.02). D222 polymorphism was detected in 40.7% of patients by UDPS, and in only 7.1% by Sanger sequencing. D222E, D222G, D222N and D222A were observed in 37.0%, 11.1%, 7.4% and 3.7% of patients, respectively; 10.7% of samples harboured more than two variants. The relative frequency of each single variant showed a wide range of intrapatient variation. D222G/N/A were detected, as either minor or predominant variants, only in severe cases, whereas D222E was equally represented in severe and moderate-mild infections. Other amino acid variants were observed at different positions within the analysed HA fragment. Consistent with higher heterogeneity, non-D222 variants were more frequently detected in severe cases than in moderate-mild cases. In addition, seven non-D222 mutations carried by minority variants, not previously described, were observed.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862843     DOI: 10.1111/j.1469-0691.2012.03984.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  18 in total

1.  Evolution of Newcastle Disease Virus Quasispecies Diversity and Enhanced Virulence after Passage through Chicken Air Sacs.

Authors:  Chunchun Meng; Xusheng Qiu; Shengqing Yu; Chuanfeng Li; Yingjie Sun; Zongyan Chen; Kaichun Liu; Xiangle Zhang; Lei Tan; Cuiping Song; Guangqing Liu; Chan Ding
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

2.  Emergence of a highly pathogenic avian influenza virus from a low-pathogenic progenitor.

Authors:  Isabella Monne; Alice Fusaro; Martha I Nelson; Lebana Bonfanti; Paolo Mulatti; Joseph Hughes; Pablo R Murcia; Alessia Schivo; Viviana Valastro; Ana Moreno; Edward C Holmes; Giovanni Cattoli
Journal:  J Virol       Date:  2014-02-05       Impact factor: 5.103

3.  The high frequency of non-aspartic acid residues at HA222 in influenza A(H1N1) 2009 pandemic viruses is associated with mortality during the upsurge of 2015: a molecular and epidemiological study from central India.

Authors:  P V Barde; M Sahu; M K Shukla; P K Bharti; R K Sharma; L K Sahare; M J Ukey; N Singh
Journal:  Epidemiol Infect       Date:  2017-08-03       Impact factor: 4.434

4.  Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum.

Authors:  Ofer Isakov; Antonio V Bordería; David Golan; Amir Hamenahem; Gershon Celniker; Liron Yoffe; Hervé Blanc; Marco Vignuzzi; Noam Shomron
Journal:  Bioinformatics       Date:  2015-02-19       Impact factor: 6.937

5.  The use of next generation sequencing in the diagnosis and typing of respiratory infections.

Authors:  Fiona Thorburn; Susan Bennett; Sejal Modha; David Murdoch; Rory Gunson; Pablo R Murcia
Journal:  J Clin Virol       Date:  2015-06-18       Impact factor: 3.168

6.  A (H1N1) pdm09 HA D222 variants associated with severity and mortality in patients during a second wave in Mexico.

Authors:  Joel A Vazquez-Perez; Pavel Isa; Darwyn Kobasa; Christopher E Ormsby; Jose E Ramírez-Gonzalez; Damaris P Romero-Rodríguez; Charlene Ranadheera; Yan Li; Nathalie Bastien; Carissa Embury-Hyatt; Elizabeth González-Duran; Gisela Barrera-Badillo; Yuria Ablanedo-Terrazas; Edgar E Sevilla-Reyes; Marina Escalera-Zamudio; Ana G Cobián-Güemes; Irma Lopez; Joanna Ortiz-Alcántara; Celia Alpuche-Aranda; Jose R Perez-Padilla; Gustavo Reyes-Terán
Journal:  Virol J       Date:  2013-01-31       Impact factor: 4.099

7.  Using high-throughput sequencing to leverage surveillance of genetic diversity and oseltamivir resistance: a pilot study during the 2009 influenza A(H1N1) pandemic.

Authors:  Juan Téllez-Sosa; Mario Henry Rodríguez; Rosa E Gómez-Barreto; Humberto Valdovinos-Torres; Ana Cecilia Hidalgo; Pablo Cruz-Hervert; René Santos Luna; Erik Carrillo-Valenzo; Celso Ramos; Lourdes García-García; Jesús Martínez-Barnetche
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

8.  Full-Genome Sequence of a Reassortant H1N1 Swine Influenza Virus Isolated from Pigs in Italy.

Authors:  Chiara Chiapponi; Laura Baioni; Andrea Luppi; Ana Moreno; Alberto Castellan; Emanuela Foni
Journal:  Genome Announc       Date:  2013-10-03

9.  A(H1N1)pdm09 hemagglutinin D222G and D222N variants are frequently harbored by patients requiring extracorporeal membrane oxygenation and advanced respiratory assistance for severe A(H1N1)pdm09 infection.

Authors:  Tina Ruggiero; Francesco De Rosa; Francesco Cerutti; Nicole Pagani; Tiziano Allice; Maria L Stella; Maria G Milia; Andrea Calcagno; Elisa Burdino; Gabriella Gregori; Rosario Urbino; Giovanni Di Perri; Marco V Ranieri; Valeria Ghisetti
Journal:  Influenza Other Respir Viruses       Date:  2013-08-09       Impact factor: 4.380

10.  Polymorphisms at residue 222 of the hemagglutinin of pandemic influenza A(H1N1)pdm09: association of quasi-species to morbidity and mortality in different risk categories.

Authors:  Paola Cristina Resende; Fernando C Motta; Maria de Lourdes A Oliveira; Tatiana S Gregianini; Sandra B Fernandes; Ana Luisa F Cury; Maria do Carmo D Rosa; Thiago Moreno L Souza; Marilda M Siqueira
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.